Allocation plan of remdesivir to states revised due to enhanced availability: Sadananda Gowda.
Union minister for Chemicals and Fertilizers, DV Sadananda Gowda on Friday mentioned the allocation plan of anti-viral drug remdesivir for all states has been revised due to its enhanced availability on account of ramping up of its manufacturing.
The elevated provide of the drug, which is getting used within the remedy of COVID-19, will assist in combating the pandemic with deeper resolve, Gowda, the chemical substances and fertilizers minister, mentioned.
In a tweet, he mentioned, “After in-depth review of enhanced availability of Remdesivir due to ramped up production, its allocation plan to all states has been revised. Its increased supply will help in fighting pandemic with deeper resolve.”
A complete of 18 lakh remdesivir vials are allotted to the states and union territories from April 21 to April 30, 2021, Gowda mentioned.
